1 2 1 1 a r t I C l e S Remyelination, the formation of myelin sheaths around demyelinated axons by newly differentiated oligodendrocytes, can occur efficiently following CNS demyelination. A major component of this regenerative process is a robust innate immune response consisting of peripherally derived macrophages and their CNS-resident counterparts, microglia. Although these microglia and macrophages are implicated in CNS autoimmune disease via secretion of toxic molecules 1 and antigen presentation to cytotoxic lymphocytes 2 , they also exhibit regenerative properties through the phagocytosis of myelin debris 3,4 and secretion of growth and neurotrophic factors 5 . Regenerative properties of macrophages following injury to muscle 6,7 and skin 8 are associated with alternative or de-activation to M2-polarized phenotypes (M2a and M2c, respectively), which secrete anti-inflammatory cytokines and growth factors 9 . In contrast, M1 'classically activated' phenotypes are associated with enhanced antigen presentation properties and secretion of pro-inflammatory cytokines and reactive oxygen and nitrogen species 9 . Here, we explored the role of microglia and macrophage polarization in remyelination, asking whether M2 phenotypes contribute to this regenerative response in the CNS and whether a study of M2-derived factors could lead to the identification of a previously unknown target for remyelination therapies.
Remyelination, the formation of myelin sheaths around demyelinated axons by newly differentiated oligodendrocytes, can occur efficiently following CNS demyelination. A major component of this regenerative process is a robust innate immune response consisting of peripherally derived macrophages and their CNS-resident counterparts, microglia. Although these microglia and macrophages are implicated in CNS autoimmune disease via secretion of toxic molecules 1 and antigen presentation to cytotoxic lymphocytes 2 , they also exhibit regenerative properties through the phagocytosis of myelin debris 3, 4 and secretion of growth and neurotrophic factors 5 . Regenerative properties of macrophages following injury to muscle 6, 7 and skin 8 are associated with alternative or de-activation to M2-polarized phenotypes (M2a and M2c, respectively), which secrete anti-inflammatory cytokines and growth factors 9 . In contrast, M1 'classically activated' phenotypes are associated with enhanced antigen presentation properties and secretion of pro-inflammatory cytokines and reactive oxygen and nitrogen species 9 . Here, we explored the role of microglia and macrophage polarization in remyelination, asking whether M2 phenotypes contribute to this regenerative response in the CNS and whether a study of M2-derived factors could lead to the identification of a previously unknown target for remyelination therapies.
RESULTS
An M1-to-M2 switch at the initiation of remyelination To examine the timing of microglia and macrophage polarization during remyelination, we induced focal demyelination by stereotaxic injection of lysolecithin into the mouse corpus callosum. Tissue was analyzed at 3, 10 and 21 d post lesion (dpl), times that correspond to key steps in the remyelination process: oligodendrocyte progenitor cell (OPC) recruitment into the lesion by proliferation and migration, initiation of remyelination by the differentiation of these OPCs into myelin-sheath forming oligodendrocytes, and completion of remyelination (Fig. 1a) [10] [11] [12] [13] . Studies of microglia and macrophages with polarization state-specific markers revealed a switch from an M1-to an M2-dominant phenotype at the initiation of remyelination. At 3 dpl, substantially more CD68 + microglia and macrophages expressed the M1 marker inducible nitric oxide synthase (iNOS) than the M2 marker arginase-1 (Arg-1) (Fig. 1b,c) . However, by 10 dpl there were more Arg-1 + CD68 + M2 cells than iNOS + CD68 + M1 cells (Fig. 1b,c) . At 21 dpl, there was a reduction in Arg-1 + M2 cells compared with at 10 dpl (Fig. 1b,c) . Only a low percentage of CD68 + microglia and macrophages remained unpolarized (iNOS − and Arg-1 − ) throughout remyelination (Fig. 1c) . The polarization switch during remyelination was confirmed using additional markers for M1 cells (tumor necrosis factor (TNF) α and CD16/32) and M2 cells (mannose receptor and insulin-like growth factor (IGF)-1) (Supplementary Fig. 1 ). We also observed the same switch from an M1-to-M2 response during remyelination in another model of demyelination induced by injection of ethidium bromide into the rat caudal cerebellar peduncles ( Supplementary Fig. 2) 14 .
As the entry of peripherally derived macrophages to function alongside CNS-resident microglia is an important part of the innate immune response in the CNS 5, 15, 16 , we next determined whether this switch in polarization phenotype was a consequence of a change in 1 2 1 2 VOLUME 16 | NUMBER 9 | SEPTEMBER 2013 nature neurOSCIenCe a r t I C l e S the balance of (differentially polarized) endogenous microglia versus peripherally derived macrophages, or of polarization switching in both populations. To exclude macrophages from lesions and to examine polarization only in microglia, we examined lesions created in C-C chemokine receptor 2 (CCR2) knockout mice (Ccr2 −/− ) whose peripheral monocytes (from which macrophages derive) cannot extravasate 4, 17 and are therefore excluded from entering remyelinating lesions 4 (Fig. 2a) . The transition from M1-to-M2 polarization still occurred as before in the microglia population in Ccr2 −/− mice, with the majority of CD68 + cells expressing iNOS at 3 dpl and Arg-1 at 10 dpl (Fig. 2b,c) . However, the absence of peripherally derived macrophages in Ccr2 −/− lesions did lead to a reduction in the total number of iNOS + M1 cells (to 37 ± 10 and 33 ± 7% of wild-type controls at 3 and 10 dpl, respectively) and Arg-1 + M2 cells (to 8 ± 8 and 40 ± 13% of wild-type controls at 3 and 10 dpl, respectively). To examine polarization only in peripherally derived macrophages in a lesion, we injected GFP-expressing wild-type bone marrow-derived cells into the circulation of lesioned Ccr2 −/− mice (Fig. 2d) . Both GFP + iNOS + M1 macrophages and GFP + Arg-1 + M2 macrophages were present at 3 and 10 dpl (Fig. 2e,f) . The iNOS + M1 population was composed of 39 ± 3% (3 dpl) and 46 ± 14% GFP + macrophages (10 dpl), whereas the Arg-1 + M2 population was composed of 63 ± 12% (3 dpl) and 68 ± 23% GFP + macrophages (10 dpl), indicating that macrophages contribute equally to both M1 and M2 npg a r t I C l e S ( Supplementary Fig. 3 ). We examined polarization by immunofluorescence, enzyme-linked immuno-absorbant assay (ELISA) and gene expression profiling, confirming that the phenotypes matched those measured in vivo during remyelination 18 ( Supplementary  Figs. 3 and 4) .
Conditioned media derived from both M1 and M2 microglia increased OPC proliferation (evidenced by increased total OPC numbers, cell cycle activity and 5-bromo-2-deoxyuridine (BrdU) incorporation; Supplementary Fig. 5a -d) and increased chemotaxic migration (Supplementary Fig. 5e ). In contrast, only M2 cell conditioned media prevented OPC apoptosis in media deprived of serum and growth factors ( Supplementary Fig. 6 ), conditions that reveal the physiological target-dependent survival mechanisms of newly formed oligodendrocytes in vivo. In addition, only M2 conditioned media increased oligodendrocyte differentiation, assessed by expression of myelin basic protein (MBP) (Fig. 3a,b ) and myelin oligodendrocyte glycoprotein (MOG) (Fig. 3c) .
M2 cell depletion inhibits oligodendrocyte differentiation
Having observed distinct effects of M1 and M2 cell conditioned media in cell culture, with only M2 cell conditioned media enhancing oligodendrocyte differentiation, we next determined the effect of selective depletion of each polarized macrophage population during remyelination in vivo. We depleted M1 cells by administration of gadolinium chloride (GdCl 3 ) in a lesion, which induces apoptosis of inflammatory macrophages via competitive inhibition of Ca 2+ mobilization and damage to plasma membranes [19] [20] [21] [22] . We confirmed the ability of GdCl 3 (270 µM) to selectively deplete M1 cells in vitro ( Supplementary Fig. 7a -c) and in a lesion in vivo by injection at the time of lesioning (Fig. 4a-c and Supplementary  Fig. 7e,f) . GdCl 3 injection did not affect M2 cell numbers (Fig. 4c) . M1 depletion reduced the density of proliferating cell nuclear antigen (PCNA) + Nkx2.2 + proliferating OPCs at 3 dpl compared with control ( Fig. 4d) , confirming a role for M1 polarization in regulating OPC proliferation. However, OPC migration (as measured by the numbers of NG2 + or Nkx2.2 + OPCs) and remyelination were not impaired ( Supplementary Fig. 7g,h) .
We depleted M2 cells using mannosylated clodronate liposomes (MCLs) that bind the mannose receptor (Fig. 5a) , which was upregulated following M2 polarization (Supplementary Fig. 3 ) and induces apoptosis in 2-3 d via clodronate-mediated depletion of intracellular iron 23, 24 . We confirmed selective M2 cell depletion in vitro ( Supplementary Fig. 8a-f) and in vivo when MCLs were injected into a lesion at 8 dpl (Fig. 5b-d and Supplementary Fig. 8g,h ). M2 cell depletion caused an increase in the number and proportion of iNOS + M1 cells ( Fig. 5d and Supplementary Fig. 8g ), supporting previous findings of reciprocal regulation between M1 and M2 polarization and associated cytokines 25, 26 . M2 depletion decreased expression of differentiation markers myelin associated glycoprotein (MAG) and MBP at 10 dpl (Fig. 5e,f) , indicating a delay in oligodendrocyte differentiation. We measured the consequent delay in remyelination in tissue at 21 dpl following M2 cell depletion in two different ways. First, we observed decreased colocalization of MBP and the more differentiated myelin marker MOG (Supplementary Fig. 8i ). Second, we demonstrated a decrease in the number of nodes of Ranvier normally indicative of compact myelin 27, 28 by showing reduced paranodal Caspr localization (flanking nodal Ankyrin-G) (Fig. 5g,h) . No change was observed in lesion area (data not shown), numbers of Nkx2.2 + OPCs, presence of neurofilament + axons, and glial fibrillary acidic protein (GFAP) + astrocyte reactivity in the lesion (Supplementary Fig. 8j-l) . a r t I C l e S Increased M2 densities during efficient remyelination Our in vivo depletion findings indicate that a switch to an M2 dominant phenotype in demyelinated lesions is required for efficient remyelination. Thus, we would predict that experimental manipulations leading to increased numbers of M2 macrophages would enhance remyelination. To confirm this, we examined parabiosis experiments in which the slow remyelination normally observed in old mice can be reversed by sharing a circulation with young mice 4 , an effect that is mediated in part by recruitment of young circulating monocytes into the demyelinating lesions of the older mice. We analyzed previously characterized tissue of lysolecithin-demyelinated ventral spinal cord of one of the two mice in various pairings 4 ( Fig. 6a) . Densities of M2 microglia and macrophages (mannose receptor + isolectin B4 + and Arg-1 + CD68 + ) were higher in the lesions of a young mouse paired with another young mouse (young/ young) than in an old mouse paired to another old mouse (old/old) (Fig. 6b,c) . Pairing of an old mouse with a young mouse (young/old), a manipulation that restores remyelination efficiency in the older mouse 4 , led to increased densities of M2 microglia and macrophages in the lesions in the older mouse relative to those seen in the old/old pairings (Fig. 6b,c) . In contrast, densities of CD16/32 + M1 microglia and macrophages were substantially higher in old/old pairings than in young/young pairings and were not reduced by young/old pairing (Fig. 6d) . Thus, increasing densities of M2 microglia and macrophages is associated with enhanced remyelination efficiency. When we analyzed parabiosis experiments between a GFP-expressing young mouse and a lesioned wild-type old mouse 4 , so as to assess the contribution of peripherally derived young macrophages (GFP + ) to the M1 and M2 polarized populations in a remyelinating lesion (Fig. 6e) , GFP + iNOS + CD68 + M1 macrophages and GFP + Arg-1 + CD68 + M2 macrophages present in the lesion (Fig. 6f) only contributed to 3.6 ± 1.6% of iNOS + M1 cells and 12.4 ± 5% of Arg-1 + M2 cells. The great majority of the increased numbers of M2 cells in the older mouse of the young/old pairings must therefore have derived from the microglia and macrophages of the old mouse, with the young macrophages that enter the lesion in the old CNS rejuvenating the lesion environment to promote M2 polarization of endogenous populations.
A second prediction of our conclusion that a switch to an M2-dominant phenotype in demyelinated lesions is required for efficient remyelination, and one critical for translational relevance, is that M2 macrophages will be abundant in areas of multiple sclerosis lesions associated with ongoing remyelination. To test this, we examined five patterns of multiple sclerosis lesion pathology (acute active, rim of chronic active, center of chronic active, chronic inactive, and remyelinated; Supplementary Table 1 ). All lesion types showed higher densities of total CD68 + microglia and macrophages and iNOS + M1 cells compared with controls (Fig. 7) . Although a few remyelinated lesions showed increased densities of mannose receptor + M2 cells compared with controls, significantly elevated numbers of M2 cells were seen only in acute active lesions and in the rim of chronic active lesions (Fig. 7c,e-g ), both areas of recent damage, where ongoing remyelination would be expected. npg a r t I C l e S M2 cell-derived activin-A drives oligodendrocyte differentiation Our data indicate that the switch to M2 polarization is an essential part of the regenerative response in the CNS by promoting oligodendrocyte differentiation. To identify an M2 cell-derived regenerative factor, we took a candidate approach and investigated the transforming growth factor (TGF) β superfamily member activin-A in light of its neuroprotective properties 29, 30 and the upregulation of its receptor (Acvr2b) during remyelination 18 . Activin-A is produced by inflammatory macrophages and is a marker of M2 polarization 31, 32 . Consistent with this, we found that more mannose receptor + M2a and M2c polarized microglia expressed activin-A in vitro in comparison to iNOS + M1 microglia (Fig. 8a) . To confirm that M2 polarized cells also contribute activin-A to the environment of remyelinating lesions, we examined expression in lesions and found that activin-A immunoreactivity was more evident in association with mannose receptor + M2 cells at 10 dpl than in iNOS + M1 cells at 3 dpl, and was reduced following M2 cell depletion with MCLs (Fig. 8b) . Examination of expression of receptors that directly bind activin-A, Acvr2A and Acvr2B, revealed that NG2 + OPCs in remyelinating lesions expressed both subtypes (Fig. 8c) . Notably, OPCs also expressed Acvr1B, the receptor that is recruited by ligand-bound Acvr2 and that is required for subsequent functional downstream signaling 33 . Together, these findings highlight the capacity of OPCs in remyelinating lesions to directly bind and respond to M2 cell-derived activin-A. Assessment of activin-A binding capacity of other cell types in lesions revealed that Acvr2 was expressed by CC1 + oligodendrocytes (Acvr2B + ) and CD68 + microglia and macrophages (Acvr2A + , Acvr2B + ), but not by GFAP + astrocytes or neurofilament + axons (Supplementary Fig. 9 ).
To test the effect of activin-A on oligodendrocyte differentiation, we exposed cultured OPCs to activin-A and found that it was sufficient to enhance oligodendrocyte differentiation (Fig. 8d) . To confirm a role for activin-A in the differentiation-promoting effect of M2 microglia, we supplemented cultures with M2 cell conditioned media and an activin-A blocking antibody and observed reduced oligodendrocyte differentiation (MBP + cells; Fig. 8e ). Given that activin-A knockout mice are neonatally lethal and that activin receptor null mutants are either developmentally lethal or have gastrulation and fertility defects 34, 35 , we investigated the role of activin-A in M2-driven oligodendrocyte differentiation during remyelination in intact CNS using ex vivo organotypic cerebellar slice cultures (Fig. 8f) . Following lysolecithin-induced demyelination, slices treated with M2 cell conditioned media during the initiation of remyelination showed increased numbers of CC1 + MBP + mature oligodendrocytes, which was considerably reduced by addition of an activin-A-blocking IgG (Fig. 8g,h ). This was a result of blocking of activin-A in M2 cell conditioned media and not of endogenous activin-A, as treatment of slices with antibody to activin-A alone did not reduce the number of oligodendrocytes relative to IgG control (Fig. 8h) . Together, these data provide a molecular mechanism for M2-driven oligodendrocyte differentiation during remyelination via secretion of activin-A. npg a r t I C l e S DISCUSSION We found that a switch occurs from M1 to M2 polarization in both resident microglia and peripherally derived macrophages in CNS lesions during remyelination. This switch occurs at 10 dpl, corresponding to the time of differentiation of oligodendrocytes derived from OPCs that have been recruited into the lesion. Using cell culture, in vivo manipulation of macrophage populations, parabiosis experiments and correlative analysis of human multiple sclerosis lesions, we found that M2 microglia and macrophages drive oligodendrocyte differentiation during remyelination and that this is an essential part of an effective remyelination response. A switch from M1-to M2-associated gene expression has been reported during cutaneous wound healing 8 , but has not been observed in studies of immune-mediated 36 and toxin (cuprizone)-induced demyelination 37 . This failure to observe a switch in different models of remyelination likely reflects the confounding effects of overlapping de-and remyelination phases in these models and the consequent difficulty in establishing any correlation with the different stages of the regenerative process. Our choice of lesion model is the most appropriate to overcome this issue, as damage occurs at the time of toxin injection, after which only the regenerative process is present.
We also found, using organotypic cerebellar slice cultures, that this M2 cell-driven regenerative response was mediated, at least in part, by secretion of the TGFβ superfamily member activin-A. Consistent with our finding, signaling pathways downstream of activin receptor activation include Rac-Cdc42 GTPases, Akt and mammalian target of rapamycin (mTOR), all of which have been implicated in positively regulating oligodendrocyte differentiation and/or myelination [38] [39] [40] [41] . In addition, TGFβ isoforms have been shown to induce myelin protein expression 42, 43 . Our finding implicating activin-A in the regulation of oligodendrocyte differentiation, together with the neuroprotective properties of activin-A 29, 30 , the expression of its receptors on OPCs in remyelinating lesions and the upregulation of its receptor during remyelination 18 , highlights this factor as a promising therapeutic target for CNS myelin regeneration.
Although previous studies investigating microglia and macrophage polarization in the context of neuronal injury have highlighted the neuroprotective properties of M2 cells 44, 45 , we identified the regenerative capacity of M2 cells in the CNS. Our results showing that M2 cells are required for oligodendrocyte differentiation are of particular interest given that a block in oligodendrocyte differentiation is a feature of chronic multiple sclerosis lesions 46 . Our results also have implications for the use of immuno-modulatory multiple sclerosis therapies; the CNS-permeable therapy FTY720 decreases peripheral M1 and M2 polarization in rodents 47 , whereas glatiramer acetate induces a peripheral M2 phenotype 48 , although any effect on central M2 polarization remains undetermined. We suggest that cell-or drug-based therapies For survival experiments, microglia were grown in serum-free media to avoid confounding pro-survival effects of serum in the conditioned media; successful polarization under these growth conditions was confirmed (data not shown). OPCs were isolated by collecting the floating fraction of 10-d-old mixed glial cultures following depletion of microglia as above, 16 h on a rotary shaker at 37 °C at 250 rpm, and depletion of astrocytes by differential adhesion. OPCs were plated in DMEM containing 4.5 g l −1 glucose, l-glutamine, pyruvate, SATO (16 µg ml −1 putrescine, 400 ng ml −1 l-thyroxine, 400 ng ml −1 tri-iodothyroxine, 60 ng ml −1 progesterone, 5 ng ml −1 sodium selenite, 100 µg ml −1 bovine serum albumin fraction V, 10 µg ml −1 insulin, 5.5 µg ml −1 halo-transferrin (all from Sigma-Aldrich)), 0.5% fetal calf serum (GIBCO), 1% penicillin/streptomycin, 10 ng ml −1 platelet-derived growth factor, and 10 ng ml −1 fibroblast growth factor-2 at 2 × 10 4 cells per well in PDL-coated plastic chamberslides (Lab-TEK). OPCs were treated for 3 d with microglia media as a control or conditioned media added in a 1:1 ratio to OPC culture media. BrdU was added to OPC cultures for 24 h before fixation. Activin-A (1-100 ng ml −1 , R&D Systems) or vehicle (0.1% BSA (wt/vol) in PBS) was added to OPCs for 3 d. Goat antibody to activin-A (βA subunit) blocking antibody (200 ng ml −1 , R&D Systems) or goat IgG control (200 ng ml −1 , Santa Cruz Biotechnology) diluted in OPC culture media was added to cultures with M2a conditioned media in a 1:1 ratio for 3 d. All assays represent a minimum of three independent experiments treated with conditioned media from at least three microglial preparations. Two to four 20× or 40× objective images were taken per condition per experiment for quantification. microglia polarization. Microglia were either left untreated or treated overnight with IFNγ (20 ng ml −1 ) and LPS (0127:B8, 100 ng ml −1 ), IL-13 (50 ng ml −1 ), or IL-10 (10 ng ml −1 ) (all from Sigma-Aldrich, <1 EU µg −1 ). Conditioned media was collected and stored at −20 °C. Contaminating astrocytes were <7% of the culture in all polarization states (data not shown). ELISAs for TNFα, IGF-1 and IL-10 were used according to the manufacturer's instructions (R&D Systems). Absorbance was read at 450 nm on a spectrophotometer and sample concentrations calculated using an equation generated from a standard curve. Three to five independent supernatant sets were used. The rapid depolarization of microglia in the absence of polarizing factors (data not shown) required these to be present during conditioning of media; polarizing factors alone were directly applied to OPCs as a control.
Protein extraction and western blotting. Lysates were generated using RIPA buffer (Thermo Scientific) supplemented with 1% protease inhibitor cocktail set III EDTA-free (vol/vol, Calbiochem). Protein concentrations were determined using the Pierce BCA Protein Assay Kit according to the manufacturer's instructions. Samples were diluted in Laemmli buffer (200 mM Tris-HCl (pH6.8), SigmaAldrich; 8% sodium dodecyl sulfate, Sigma-Aldrich; 40% glycerol, BioRad; 0.2% npg
